Tata stakeholders may seek an arbitrator, likely a retired Supreme Court chief justice, to determine the appointment of trustees for the Ratan Tata Endowment Foundation (RTEF) amidst unclear instructions left by Ratan Tata. The foundation, focused on philanthropy and research, will be independent of Tata Trusts. The arbitration could set a precedent for legacy foundation governance in India.
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.